Intracystic evaluation of tumor markers in benign and malignant ovarian pathology

European Journal of Gynaecological Oncology

Volumn 23, Issue 2, 2002, Pages 163-165

  Cherchi, P L ^a   Capobianco, G ^a   Ambrosini, G ^a   Fadda, G M ^a   Piga, M D ^a   Ruiu, G ^a   Fattorini, F ^a   Dessole, S ^a  

^a NONE   (Italy)

Author keywords

CA 125, CA 15.3, TPA, CA 19.9 and CEA; Cystic ovarian pathology; Serum and intracystic fluid evaluation

Indexed keywords

CA 125 ANTIGEN; CA 15-3 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TISSUE POLYPEPTIDE ANTIGEN; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD LEVEL; EVALUATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVARY ADENOCARCINOMA; OVARY CANCER; OVARY CARCINOMA; OVARY CYST; OVARY TUMOR; BODY FLUID; CHEMISTRY; CYTOLOGY; DIFFERENTIAL DIAGNOSIS; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; BODY FLUIDS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MIDDLE AGED; OVARIAN CYSTS; OVARIAN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0036010337     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Preoperative determination of several serum tumor markers in patients with primary epithelial ovarian carcinoma
2. A radioimmunoassay using monoclonal anti-body to monitor the course of epithelial ovarian cancer
3. The CA 125 tumor-associated antigen: A review of the literature
4. CA 125 and polymorphic epithelial mucin as serum tumor markers
5. Cancer-associated antigen CA 195 in patients with mucinous ovarian tumours: A comparative analysis with CEA, TATI and CA 125 in serum specimens and cyst fluids
6. The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: Relevance for differential diagnosis
7. Serum CA-125 in the evaluation of benign adnexal cysts
8. CA 125 levels measured in different phases of the menstrual cycle in screening for endometriosis
9. FIGO stages "1988 revision"
10. Transvaginal sonographic characterization of ovarian disease: Evaluation of a new scoring system to predict ovarian malignancy
11. Differentiating malignant from benign ovarian tumors with transvaginal color flow imaging
12. Tumor markers in gynecologic oncology
13. Cyst fluid CA 125 levels in ovarian epithelial neoplasms
14. Is differentiation of benign and malignant cystic adnexal masses possible by evaluation of cysts fluids with respect to color, cytology, steroid hormones and tumor markers?
15. CA 125 and carcinoembryonic antigen levels in cyst fluid, ascites and serum of patients with ovarian neoplasms
16. Explanation of the limited correlation between tumor CA-125 content and serum CA-125 antigen levels in patients with ovarian tumors
17. Comparison of carcinoembryonic antigen levels between portal and peripheral blood in patients with colorectal cancer. Correlation with histopathologic variables
18. Measurements of CA-125, carcino-embryonic antigen and alphafetoprotein in ovarian cyst fluids: Diagnostic adjunct to cytology
19. Tumour associated antigens in diagnosis of serous effusions